Radiology Grand Rounds
Coronary CTA in 2025 and Beyond
Todd C. Villines, MD
October 16, 2025
Q-207B
DESCRIPTION:
The University of Chicago Radiology Grand Rounds represent a series of lectures given by invited experts on all aspects of radiology. Several dates are reserved each year for DEI speakers.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
- Understand the current guideline-based utilization of coronary CTA
- Review the potential clinical utilization of advanced plaque quantification on coronary CTA
- Understand the evolving role of pericoronary fat attenuation in cardiovascular risk assessment using coronary CTA
ACCREDITATION AND CREDIT DESIGNATION
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
COMMERCIAL SUPPORT
This CME certified activity has not requested or received any support or funding from ineligible companies. This includes, but is not limited to, pharmaceutical companies, and medical device manufacturers.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Program Director Disclosure(s):
Drs. Lydia Chelala, Nicholas Feinberg and Grace Lee have no relevant financial relationships with ineligible companies to disclose.
Carina Yang, MD is a consultant for Guerbet.
Planning Committee Member Disclosure(s): Aurora Castaneda has no relevant financial relationships with ineligible companies to disclose.
Speaker(s) Disclosure(s): Todd Villines, MD, FACC, FAHA, MSCCT is a Consultant and Research Study Advisor for Abcentra, HeartFlow, Cleerly, and Milestone Pharmaceuticals .
All of the relevant financial relationships listed for these individuals have been mitigated.
The staff of the Center for Continuing Medical Education have no financial relationships to disclose.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
DISCLAIMER
The views expressed in this activity are those of the individual speaker. It should not be inferred or assumed that they are expressing the views of any pharmaceutical or product/device manufacturer, provider of commercial services, or The University of Chicago. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.
Copyright © 2025 University of Chicago. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from The University of Chicago Center for Continuing Medical Education.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation

Facebook
X
LinkedIn
Forward